Tilapertin structure
|
Common Name | Tilapertin | ||
---|---|---|---|---|
CAS Number | 1000690-85-6 | Molecular Weight | 378.388 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 455.3±45.0 °C at 760 mmHg | |
Molecular Formula | C20H21F3N2O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 229.2±28.7 °C |
Use of TilapertinTilapertin is an oral inhibitor of glycine transporter type-1 (GlyT1). |
Name | Tilapertin |
---|---|
Synonym | More Synonyms |
Description | Tilapertin is an oral inhibitor of glycine transporter type-1 (GlyT1). |
---|---|
Related Catalog | |
Target |
GlyT1[1] |
In Vivo | Tilapertin is a nanomolar potent, orally bioavailable and selective GlyT1 inhibitor. Oral administration of Tilapertin dose-dependently increases cerebrospinal fluid (CSF) glycine concentration in rats[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 455.3±45.0 °C at 760 mmHg |
Molecular Formula | C20H21F3N2O2 |
Molecular Weight | 378.388 |
Flash Point | 229.2±28.7 °C |
Exact Mass | 378.155518 |
LogP | 2.95 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.554 |
Storage condition | 2-8℃ |
(4-{(R)-Phenyl[3-(trifluoromethyl)phenyl]methyl}-1-piperazinyl)acetic acid |
tilapertin |
1-Piperazineacetic acid, 4-[(R)-phenyl[3-(trifluoromethyl)phenyl]methyl]- |
A2SV488G98 |